NP
Nacuity Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Fort Worth, TX
Amount raised$8.4Msold at filing
Total offering$30M$21.6M still open
Investors in the raise98count reported to the SEC
FiledDec 30, 2025first sale Dec 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael WallExecutive Officer
Robin SteeleDirector
David WohlbergExecutive Officer, Director
Rusty KelleyDirector
Gerald CagleDirector
Jami KernExecutive Officer
Benjamin YerxaDirector
Emmett Cunningham, Jr.Director
Halden ConnerExecutive Officer, Director
Charles LieserExecutive Officer
Executive officers, directors and promoters as listed on the Form D.